By Sheeba M. | June 2, 2026
Aurora Cannabis vs. Canopy Growth: Valuation Divergence Signals Recovery
The cannabis sector’s “value trap” narrative is breaking apart. Two Canadian giants—ACB and CGC—are now trading at dramatically different multiples despite comparable revenue bases and improving unit economics. This divergence suggests the market is beginning to differentiate between operational discipline and growth-at-all-costs strategies.
The Numbers: Aurora Cannabis is valued at ~$380M market cap on $410M trailing twelve-month revenue (0.93x EV/Revenue). Canopy Growth trades at $2.1B market cap on ~$1.15B TTM revenue (1.83x EV/Revenue). Both companies are EBITDA-positive, but Aurora achieved profitability a quarter earlier and with lower capex intensity.
What Changed: Six months ago, investors viewed both stocks as troubled legacy LPs destined for decline. Aurora’s execution of its “asset-light” strategy—divesting non-core assets and rightsizing cultivated production—finally resonated with the market. The company is now generating positive free cash flow, with Q1 2026 FCF of $12M, compared to negative $8M in the prior year period.
The Arbitrage Case
If Aurora reaches parity with Canopy’s 1.6x revenue multiple (reasonable given superior cash generation), the stock has 70% upside from current levels. However, several risks remain: Canadian cannabis regulatory changes, U.S. rescheduling delays, and competitive pressure from MSOs growing indoor flower at lower cost.
Timing Matters: The next catalyst is Q2 earnings (late July/early August). If Aurora delivers another quarter of positive FCF and customer acquisition at scale, the valuation gap likely compresses further. Conversely, if Q2 shows margin pressure or slowing demand growth, the risk-off trade could accelerate.
Investors should monitor OGI (Organigram Holdings) as well—trading at 0.8x revenue with even tighter cash generation profile, suggesting the entire Canadian LP sector may be re-rating upward.
Sources
- SEC EDGAR — Public company filings
- Stock Analysis — Financial metrics and comparables
- Aurora Cannabis Investor Relations — Company guidance and forecasts
Track cannabis stocks with the Weedstock Real-Time Tracker